Skip to content

Drug interactions

Atomoxetine + Lapatinib

Severity: Moderate

Atomoxetine and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib can prolong the QT interval, and atomoxetine has been linked to QT effects mainly in overdose or in poor CYP2D6 metabolizers. Combined use may add to arrhythmia risk, particularly in patients with other risk factors.

What this interaction means in plain words

Atomoxetine and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Atomoxetine belongs to Central Nervous System; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Obtain a baseline ECG and monitor it during therapy, and keep potassium and magnesium within normal range. Avoid other QT-prolonging drugs where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atomoxetine and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atomoxetine with Lapatinib?

MediHelp rates the interaction as moderate. Atomoxetine and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib can prolong the QT interval, and atomoxetine has been linked to QT effects mainly in overdose or in poor CYP2D6 metabolizers. Combined use may add to arrhythmia risk, particularly in patients with other risk factors.

How serious is the interaction between Atomoxetine and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor it during therapy, and keep potassium and magnesium within normal range. Avoid other QT-prolonging drugs where possible.

What other medicines interact with Atomoxetine?

MediHelp also lists interactions of Atomoxetine with, for example, Isocarboxazid, Linezolid, Phenelzine. The full list is on the Atomoxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in